Add to ORKGA prospective study on the use of rivastigmine transdermal patch in Alzheimer’s dementia in a routine clinical settin
Background/Aims: In dementia patients, a deficit in activities of daily living (ADL) is one of the m...
Cholinesterase inhibitors have all been available in oral formulations, but a rivastigmine transderm...
This study was designed to perform MRS of the Temporal Lobe (TL) and Frontal Lobe (FL) to assess bra...
Abstract There is not much published literature on the use of rivastigmine patch in a "routine" clin...
Alzheimer’s disease (AD) patients treated with rivastigmine transdermal patch have shown statistical...
Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Ga...
doi: 10.3389/fnagi.2014.00179 Comparison of the effects of transdermal and oral rivastigmine on cogn...
Objectives: The primary objective of this multicentre, prospective, observational study was to asses...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Full list of author information is available at the end of the articlesevere Alzheimer’s disease (AD...
Abstract Objectives: To conduct a preliminary assessment of the effects of the oral and transdermal...
Oral donepezil and rivastigmine are two commonly used cholinesterase inhibitors (ChEIs) used in Alzh...
Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Ga...
rivastigmine patch is widely used as a cognitive enhancer in Alzheimer’s-type dementia. There are ve...
Secundino López-Pousa,1 Francisco Javier Arranz21Unit for Assessment of Memory and Dement...
Background/Aims: In dementia patients, a deficit in activities of daily living (ADL) is one of the m...
Cholinesterase inhibitors have all been available in oral formulations, but a rivastigmine transderm...
This study was designed to perform MRS of the Temporal Lobe (TL) and Frontal Lobe (FL) to assess bra...
Abstract There is not much published literature on the use of rivastigmine patch in a "routine" clin...
Alzheimer’s disease (AD) patients treated with rivastigmine transdermal patch have shown statistical...
Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Ga...
doi: 10.3389/fnagi.2014.00179 Comparison of the effects of transdermal and oral rivastigmine on cogn...
Objectives: The primary objective of this multicentre, prospective, observational study was to asses...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Full list of author information is available at the end of the articlesevere Alzheimer’s disease (AD...
Abstract Objectives: To conduct a preliminary assessment of the effects of the oral and transdermal...
Oral donepezil and rivastigmine are two commonly used cholinesterase inhibitors (ChEIs) used in Alzh...
Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Ga...
rivastigmine patch is widely used as a cognitive enhancer in Alzheimer’s-type dementia. There are ve...
Secundino López-Pousa,1 Francisco Javier Arranz21Unit for Assessment of Memory and Dement...
Background/Aims: In dementia patients, a deficit in activities of daily living (ADL) is one of the m...
Cholinesterase inhibitors have all been available in oral formulations, but a rivastigmine transderm...
This study was designed to perform MRS of the Temporal Lobe (TL) and Frontal Lobe (FL) to assess bra...